Cell-cell interactions in the heart: advanced cardiac models and omics technologies

S Tan, J Yang, S Hu, W Lei - Stem Cell Research & Therapy, 2024 - Springer
A healthy heart comprises various cell types, including cardiomyocytes, endothelial cells,
fibroblasts, immune cells, and among others, which work together to maintain optimal …

Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments

G Basara, G Bahcecioglu, SG Ozcebe, BW Ellis… - Biophysics …, 2022 - pubs.aip.org
In the modern world, myocardial infarction is one of the most common cardiovascular
diseases, which are responsible for around 18 million deaths every year or almost 32% of all …

[HTML][HTML] Central role of the p53 pathway in the noncoding-RNA response to oxidative stress

P Fuschi, M Carrara, C Voellenkle… - Aging (Albany …, 2017 - ncbi.nlm.nih.gov
Oxidative stress plays a fundamental role in many conditions. Specifically, redox imbalance
inhibits endothelial cell (EC) growth, inducing cell death and senescence. We used global …

[HTML][HTML] Engineered circulatory scaffolds for building cardiac tissue

S Huang, Y Yang, Q Yang, Q Zhao… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Heart failure (HF) is the terminal state of cardiovascular disease (CVD), leading numerous
patients to death every year. Cardiac tissue engineering is a multidisciplinary field of …

CRISPR/Cas9 edited induced pluripotent stem cell-based vascular tissues to model aging and disease-dependent impairment

A Acun, P Zorlutuna - Tissue Engineering Part A, 2019 - liebertpub.com
The discovery of induced pluripotent stem cells (iPSCs) and advancements in genome
editing technology introduced a new perspective to disease modeling as genetic factors can …

Revealing the pathogenic changes of PAH based on multiomics characteristics

L Zhang, S Chen, X Zeng, D Lin, Y Li, L Gui… - Journal of Translational …, 2019 - Springer
Background Pulmonary artery hypertension (PAH), which is characterized by an increase in
pulmonary circulation blood pressure, is a fatal disease, and its pathogenesis remains …

Advances in the design, generation, and application of tissue-engineered myocardial equivalents

G Bernava, L Iop - Frontiers in Bioengineering and Biotechnology, 2023 - frontiersin.org
Due to the limited regenerative ability of cardiomyocytes, the disabling irreversible condition
of myocardial failure can only be treated with conservative and temporary therapeutic …

3D bioprinted aged human post‐infarct myocardium tissue model

G Basara, LE Celebi, G Ronan… - Health Science …, 2024 - Wiley Online Library
Abstract Background and Aims Fibrotic tissue formed after myocardial infarction (MI) can be
as detrimental as MI itself. However, current in vitro cardiac fibrosis models fail to …

GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humans

Y Yao, P Du Jiang, BN Chao, D Cagdas… - Journal of Experimental …, 2022 - rupress.org
Inborn errors of immunity (IEIs) unveil regulatory pathways of human immunity. We describe
a new IEI caused by mutations in the GTPase of the immune-associated protein 6 (GIMAP6) …

[HTML][HTML] 类器官和立体细胞模型在中药心脏毒性评价中的应用前景

刘昕彦, 邵瑞, 贺爽, 朱彦 - 药学学报, 2019 - html.rhhz.net
心脏毒性是导致药物研发失败和上市后撤市的原因之一. 然而, 目前的药物心脏毒性评价方法
存在临床相关性低, 重现性低, 处理量小等缺点. 建立准确可靠的方法评价药物的心脏毒性是当前 …